InspireMD Inc. logo

InspireMD Inc.

NSPR | NASDAQ
Chart Builder DCF Calculator
$0.76
+$0.01 (+1.33%)
Sep 22, 2026, 12:17 PM ET · Market open

Company Profile

InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic protection systems. The MGuard Prime systems are crucial for patients experiencing acute coronary syndromes, notably acute myocardial infarction, and those undergoing saphenous vein graft coronary interventions or bypass surgery. InspireMD is also developing PVGuard, an innovative solution combining a MicroNet mesh sleeve with a self-expandable stent, aimed at peripheral vascular applications.

Key Executives

Name Position
Marvin L. Slosman President, Chief Executive Officer & Director
Amir Kohen Executive Vice President of Finance & Regional Manager
Donna DeChant Vice President of Human Resources & Organizational Development
Kathleen Kennedy Senior Vice President of Global Sales & Marketing
Michael A. Lawless CFO, Secretary & Treasurer
Pete Ligotti Executive Vice President & GM of North America
Peter A. Soukas Chief Medical Officer
Shane Thomas Gleason Chief Commercial Officer
Sol J. Barer Special Advisor to the Board

Latest SEC Filings

Date Type Title
Aug 17, 2026 8-K Current Report
Aug 14, 2026 10-Q Quarterly Report
Jul 29, 2026 8-K Current Report
Jul 23, 2026 8-K Current Report
Jul 02, 2026 8-K Current Report
Jun 11, 2026 8-K Current Report
May 29, 2026 4 Filing
May 22, 2026 8-K Current Report
May 21, 2026 4 Filing
May 15, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
View All SEC Filings
InspireMD Inc.
InspireMD Inc. logo
Country United States
IPO Date Apr 11, 2011
Industry Medical - Devices
Sector Healthcare
Employees 127
CEO Marvin L. Slosman

Contact Details

6303 Waterford District Drive Miami, Florida 33126 United States

Stock Details

Ticker Symbol NSPR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001433607
CUSIP Number 45779A846
ISIN Number US45779A8466
SIC Code 3841

© 2026 bestshares.com. All rights reserved.